Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

IOVA Iovance Biotherapeutics Inc

9,3844

0,8344 (9,76%)

26 Nov 2024 - Geschlossen

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Iovance Biotherapeutics (NASDAQ:IOVA)
Historical Stock Chart
Von Okt 2024 bis Nov 2024

Click Here for more Iovance Biotherapeutics Charts.

Iovance Biotherapeutics (NASDAQ:IOVA)
Historical Stock Chart
Von Nov 2023 bis Nov 2024

Click Here for more Iovance Biotherapeutics Charts.

News Iovance Biotherapeutics Inc

Form 8-K - Current report
Donnerstag 21 November 2024 (4 Tage vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 7 November 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 7 November 2024 (3 Wochen vor) • Edgar (US Regulatory)

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024
Donnerstag 7 November 2024 (3 Wochen vor) • GlobeNewswire Inc.

Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2024 Financial Results Conference Call and Webcast on Thursday, November 7, 2024
Donnerstag 31 Oktober 2024 (4 Wochen vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 17 Oktober 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 17 Oktober 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 17 Oktober 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 6 September 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 6 September 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 6 September 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 6 September 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Iovance Biotherapeutics Inc News-Artikel

Deutsche Telekom (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen